KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Change in Receivables (2017 - 2025)

Johnson & Johnson (JNJ) has disclosed Change in Receivables for 17 consecutive years, with -$391.0 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables rose 54.16% to -$391.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 billion through Dec 2025, up 338.67% year-over-year, with the annual reading at $1.8 billion for FY2025, 338.67% up from the prior year.
  • Change in Receivables hit -$391.0 million in Q4 2025 for Johnson & Johnson, down from -$111.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $1.6 billion in Q2 2021 to a low of -$1.2 billion in Q1 2021.
  • Historically, Change in Receivables has averaged $184.1 million across 5 years, with a median of $174.0 million in 2021.
  • Biggest YoY gain for Change in Receivables was 416.67% in 2024; the steepest drop was 275.77% in 2024.
  • Year by year, Change in Receivables stood at $252.0 million in 2021, then soared by 69.44% to $427.0 million in 2022, then tumbled by 153.16% to -$227.0 million in 2023, then tumbled by 275.77% to -$853.0 million in 2024, then skyrocketed by 54.16% to -$391.0 million in 2025.
  • Business Quant data shows Change in Receivables for JNJ at -$391.0 million in Q4 2025, -$111.0 million in Q3 2025, and $1.4 billion in Q2 2025.